Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, Parkinson’s...
I-Mab Biopharma (“I-Mab”), a clinical stage biotech company exclusively focusing on discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, announces on June 24, 2019, that the first patient has been dosed in a Phase I...
ThoughtSphere, a fast growing, cloud-based clinical data hub and analytics SaaS company, today announced that Navitas Life Sciences, a full service CRO, and technology-led life sciences service provider, chose ThoughtSphere to power OneClinical Analytics, which is an...
Clinical investigators will study the safety and efficacy of this microvascular device designed to restore blood flow and reduce amputations resulting from below-the-knee peripheral artery disease WILMINGTON, Mass., June 24, 2019 — Micro Medical Solutions (MMS)...
First engineered, GMP-grade, cryopreserved, off-the-shelf, bi-specific NK cell therapy to enter human clinical trials targeting PD-L1 and CD16 in patients with solid tumors NantKwest establishes a leading portfolio of off-the-shelf NK cells at clinical stage of...
Email
Text